Gelain Arianna

Researcher
SSD
CHIM/08 - PHARMACEUTICAL CHEMISTRY
Competition sector
03/D1 - MEDICINAL, TOXICOLOGICAL AND NUTRITIONAL CHEMISTRY AND APPLIED TECHNOLOGIES

Contacts

Workplace

Via Mangiagalli, 25
20133 MILANO (MI)

Office phone number
02503 19369
University email address
Research

Publications

Publications
  • Synthesis, Characterization, and Biological Evaluation of New Derivatives Targeting MbtI as Antitubercular Agents / M. Mori, G. Stelitano, L.R. Chiarelli, G. Cazzaniga, A. Gelain, D. Barlocco, E.R.E. Pini, F. Meneghetti, S. Villa. - In: PHARMACEUTICALS. - ISSN 1424-8247. - 14:2(2021 Feb 13).
  • Identification of the mechanism of action of 5,6-dimethyl-1H,3H-2,1,3-benzothiadiazole-2,2-dioxide as STAT3 inhibitor / E. Gilardoni, M. Mori, S. Villa, A. Gelain, L.G. Regazzoni. ((Intervento presentato al 5. convegno Chicago Mass Spec Day tenutosi a online nel 2020.
  • Towards the Inhibition of Protein–Protein Interactions (PPIs) in STAT3: Insights into a New Class of Benzothiadiazole Derivatives / M. Mori, E. Gilardoni, L. Regazzoni, A. Pedretti, D. Colombo, G. Parkinson, A. Asai, F. Meneghetti, S. Villa, A. Gelain. - In: MOLECULES. - ISSN 1420-3049. - 25:15(2020 Jul 31).
  • Investigating the inhibition mechanism and catalytic cycle of MbtI, the salicylate synthase from Mycobacterium tuberculosis / M. Mori, S. Villa, A. Gelain, E.R.E. Pini, G. Stelitano, L.R. Chiarelli, T. Tuccinardi, M. Bellinzoni, F. Meneghetti. ((Intervento presentato al convegno Italian Young Medicinal Chemistry Virtual Meeting tenutosi a / nel 2020.
  • Shedding X-ray light on the role of magnesium in the activity of M. tuberculosis salicylate synthase (MbtI) for drug design / M. Mori, G. Stelitano, A. Gelain, E. Pini, L.R. Chiarelli, J.C. Sammartino, G. Poli, T. Tuccinardi, G. Beretta, A. Porta, M. Bellinzoni, S. Villa, F. Meneghetti. - In: JOURNAL OF MEDICINAL CHEMISTRY. - ISSN 0022-2623. - 63:13(2020 Jul 09), pp. 7066-7080.